Custom 3D Tumor Model Development

Development of customized 3D tumor models designed to support translational oncology research, assay development, and preclinical drug evaluation.

NAMina Bio designs and coordinates 3D model-development workflows using human-relevant cancer biology, tunable microenvironment design, and assay-compatible 3D culture strategies.

This service may include:

• Cell-line, organoid, tumoroid, or patient-derived model planning• 3D architecture selection for imaging, screening, or downstream molecular analysis• Matrix and microenvironment design considerations• Tumor-only, tumor–stroma, or tumor–immune model configuration• Pilot model generation and assay-readiness evaluation• Morphology, viability, and phenotypic QC strategy• Draft experimental workflow and model-development report

Potential applications include: pancreatic cancer, colorectal cancer, breast cancer, glioblastoma, solid tumor resistance studies, tumor microenvironment modeling, and assay optimization.

Best for: teams that need a biologically relevant 3D tumor model before moving into drug testing, biomarker studies, or translational profiling.

Research use only. Human-sample projects require appropriate ethics, consent, and material-transfer documentation.